Literature DB >> 29631192

Daytime microsleeps during 7 days of sleep restriction followed by 13 days of sleep recovery in healthy young adults.

Clément Bougard1, Danielle Gomez-Merino2, Arnaud Rabat2, Pierrick Arnal2, Pascal Van Beers2, Mathias Guillard2, Damien Léger3, Fabien Sauvet2, Mounir Chennaoui2.   

Abstract

We investigated the consequences of sleep restriction (SR) on maintenance of wakefulness capacities and diurnal sleepiness through microsleeps monitoring. 12 healthy males (20-36 years old) were sleep restricted (4 h per night) during 7 nights followed by 13 nights of recovery sleep. Participants completed Karolinska Sleepiness Scale (KSS) and Maintenance of Wakefulness Test (MWT) at baseline (B), during SR (SR1, SR4 and SR7) and during recovery (R3 and R13), while continuously recorded for EEG analysis. During SR, MWT latencies decreased (SR7: -24.4%), whereas the number, the cumulative duration of microsleeps and KSS scores increased. Recovery nights allowed MWT latencies, KSS scores and all sleep values to return to baseline levels, while a rebound in N3, N3% and REM% sleep stages occurred. During SR, the maintenance of N3 sleep duration seems not sufficient to reduce daytime sleepiness and MWT results did not reflect the sleepiness levels characterized by persistent sleep attacks.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Daytime sleepiness; Microsleeps; Recovery; Sleep restriction; Sleep stages

Mesh:

Year:  2018        PMID: 29631192     DOI: 10.1016/j.concog.2018.03.008

Source DB:  PubMed          Journal:  Conscious Cogn        ISSN: 1053-8100


  2 in total

1.  Automatically Detected Microsleep Episodes in the Fitness-to-Drive Assessment.

Authors:  Jelena Skorucak; Anneke Hertig-Godeschalk; Peter Achermann; Johannes Mathis; David R Schreier
Journal:  Front Neurosci       Date:  2020-01-23       Impact factor: 4.677

2.  Microsleep assessment enhances interpretation of the Maintenance of Wakefulness Test.

Authors:  Angela M Anniss; Alan Young; Denise M O'Driscoll
Journal:  J Clin Sleep Med       Date:  2021-08-01       Impact factor: 4.324

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.